CHSCL vs BG

For growth investors, Bunge Global S.

A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -9. 7% for CHS Inc. (CHSCL). Bunge Global S. A. (BG) offers the better valuation at 25. 2x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Bunge Global S. A. (BG) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Bunge Global S.

A. (BG) delivered a total return of +49. 4%, compared to +21. 4% for CHS Inc. (CHSCL). Over 10 years, the gap is even starker: BG returned +140. 3% versus CHSCL's +59. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CHS Inc.

(CHSCL) is the lower-risk stock at 0. 10β versus Bunge Global S. A. 's 0. 25β — meaning BG is approximately 158% more volatile than CHSCL relative to the S&P 500. On balance sheet safety, CHS Inc. (CHSCL) carries a lower debt/equity ratio of 29% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bunge Global S.

A. (BG) is pulling ahead at 32. 4% versus -9. 7% for CHS Inc. (CHSCL). Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CHS Inc.

(CHSCL) is the more profitable company, earning 1. 7% net margin versus 1. 2% for Bunge Global S. A. — meaning it keeps 1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BG leads at 1. 5% versus 0. 3% for CHSCL. At the gross margin level — before operating expenses — BG leads at 4. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BG (2.

2% yield) pays a dividend. CHSCL does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Bunge Global S.

A. (BG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 25), 2. 2% yield, +140. 3% 10Y return). Both have compounded well over 10 years (BG: +140. 3%, CHSCL: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CHSCL is a small-cap quality compounder stock; BG is a mid-cap high-growth stock. BG pays a dividend while CHSCL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.